William Chu

5.3k total citations
161 papers, 2.9k citations indexed

About

William Chu is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, William Chu has authored 161 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 62 papers in Radiation and 35 papers in Surgery. Recurrent topics in William Chu's work include Advanced Radiotherapy Techniques (61 papers), Prostate Cancer Diagnosis and Treatment (52 papers) and Prostate Cancer Treatment and Research (52 papers). William Chu is often cited by papers focused on Advanced Radiotherapy Techniques (61 papers), Prostate Cancer Diagnosis and Treatment (52 papers) and Prostate Cancer Treatment and Research (52 papers). William Chu collaborates with scholars based in Canada, United States and Australia. William Chu's co-authors include Steven A. Narod, Patrick Cheung, Hans T. Chung, Danny Vesprini, Andrew Loblaw, M. P. McCormick, Helena Jernström, Anand Swaminath, Liying Zhang and Robert E. Veiga and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Geophysical Research Atmospheres and PLoS ONE.

In The Last Decade

William Chu

152 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Chu Canada	29	1.3k	654	632	558	479	161	2.9k
Lawrence B. Levy United States	37	1.8k 1.3×	847 1.3×	508 0.8×	1.1k 2.0×	704 1.5×	115	4.1k
Danny Vesprini Canada	35	2.5k 1.9×	695 1.1×	1.0k 1.6×	1.0k 1.8×	828 1.7×	159	4.9k
T.A. DeWees United States	35	1.7k 1.3×	1.1k 1.7×	403 0.6×	808 1.4×	826 1.7×	174	3.9k
Gina Lockwood Canada	25	1.3k 1.0×	389 0.6×	756 1.2×	629 1.1×	518 1.1×	93	3.4k
Kenneth Russell United States	32	1.8k 1.4×	734 1.1×	459 0.7×	678 1.2×	443 0.9×	120	3.5k
Hideya Yamazaki Japan	35	2.1k 1.6×	983 1.5×	486 0.8×	914 1.6×	1.4k 2.8×	329	4.8k
Zelig Tochner United States	33	1.8k 1.4×	883 1.4×	429 0.7×	292 0.5×	405 0.8×	113	3.4k
G.R. Kerr United Kingdom	31	1.1k 0.8×	304 0.5×	229 0.4×	1.1k 2.0×	1.2k 2.4×	97	3.2k
David H. Hussey United States	37	1.8k 1.4×	787 1.2×	300 0.5×	649 1.2×	1.1k 2.2×	125	4.2k
Jan Tennvall Sweden	35	1.2k 0.9×	468 0.7×	403 0.6×	1.4k 2.6×	895 1.9×	130	4.9k

Countries citing papers authored by William Chu

Since Specialization

Citations

This map shows the geographic impact of William Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Chu more than expected).

Fields of papers citing papers by William Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Chu. The network helps show where William Chu may publish in the future.

Co-authorship network of co-authors of William Chu

This figure shows the co-authorship network connecting the top 25 collaborators of William Chu. A scholar is included among the top collaborators of William Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Chu. William Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Simeng, William Chu, Xinyu Zhang, et al.. (2025). Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism Underlying Ligusticum chuanxiong ’s Alleviation of Hyperlipidemia. Chemistry & Biodiversity. 22(12). e01282–e01282.

Ong, Wee Loon, Harvey Quon, Patrick Cheung, et al.. (2024). Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials. International Journal of Radiation Oncology*Biology*Physics. 121(2). 325–330. 2 indexed citations

Chu, William, Amandeep Taggar, Yee Ung, et al.. (2023). Risk-adjusted chemoradiation according to human papilloma viral status for anal cancer: a pilot study. Frontiers in Oncology. 13. 1183854–1183854. 2 indexed citations

Song, Jiheon, Mark T. Corkum, Andrew Loblaw, et al.. (2023). 44 Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer. Radiotherapy and Oncology. 186. S22–S23.

Song, Jiheon, Mark T. Corkum, D.A. Loblaw, et al.. (2023). Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e438–e439. 1 indexed citations

Donovan, E., Alexander V. Louie, William Chu, et al.. (2022). Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC). Clinical Genitourinary Cancer. 20(5). e353–e361. 6 indexed citations

Glicksman, Rachel, Patrick Cheung, Darby Erler, et al.. (2022). Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes. Clinical Oncology. 35(1). 20–28. 12 indexed citations

Glicksman, Rachel, Andrew Loblaw, Gerard Morton, et al.. (2021). Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial. Radiotherapy and Oncology. 163. 21–31. 12 indexed citations

Jabaji, Ramzi, et al.. (2020). Primary Renal Carcinoid Tumor: Report of Two Cases. The Permanente Journal. 24(2). 6 indexed citations

10.

Correa, Rohann, Alexander V. Louie, Nicholas G. Zaorsky, et al.. (2019). Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio’s Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. https://doi.org/10.1016/j.euf.2019.06.002. [Epub ahead of print]. European Urology Focus. 7(2). 404–405. 1 indexed citations

11.

Mahadevan, Lakshmi Shree Kulumani, Jim Zhong, Bhanu Prasad Venkatesulu, et al.. (2018). Imaging predictors of treatment outcomes in rectal cancer: An overview. Critical Reviews in Oncology/Hematology. 129. 153–162. 17 indexed citations

12.

Detsky, Jay, Laurent Milot, Yoo‐Joung Ko, et al.. (2018). Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy. Physics and Imaging in Radiation Oncology. 5. 9–12. 5 indexed citations

13.

Musunuru, Hima Bindu, Laura D’Alimonte, Melanie Davidson, et al.. (2018). Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life. International Journal of Radiation Oncology*Biology*Physics. 102(5). 1438–1447. 41 indexed citations

14.

Sodergren, Samantha C., Colin D. Johnson, Alexandra Gilbert, et al.. (2017). Phase I–III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer. Radiotherapy and Oncology. 126(2). 222–228. 31 indexed citations

15.

Chu, William, et al.. (2016). Implementation of a volumetric modulated arc therapy treatment planning solution for kidney and adrenal stereotactic body radiation therapy. Medical dosimetry. 41(4). 323–328. 5 indexed citations

16.

Korol, Renée, Melanie Davidson, A. Karotki, et al.. (2011). Evaluation of Patient Immobilization for Liver SBRT. International Journal of Radiation Oncology*Biology*Physics. 81(2). S781–S781. 1 indexed citations

17.

Chu, William, Anthony Fyles, Edward M. Sellers, et al.. (2007). Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use. Carcinogenesis. 28(10). 2139–2142. 29 indexed citations

18.

Moslehi, Roxana, William Chu, Beth Y. Karlan, et al.. (2000). BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer. The American Journal of Human Genetics. 66(4). 1259–1272. 224 indexed citations

19.

Salmena, Leonardo, Jodi Lees, William Chu, et al.. (1999). p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin. Leukemia Research. 23(10). 871–880. 27 indexed citations

20.

Mcmaster, L. R., et al.. (1992). SAGE 1 data user's guide. NASA Technical Reports Server (NASA). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact